How can the inversion move forward if the Treasury has introduced rules to deter companies from using the tax strategy ? The government ' s rules aren ' t broad enough to stop Allergan and Pfizer from using the tactic . The Treasury Department ' s regulations bar corporations from inversions if the shareholders of the old U . S . parent company own at least 60 percent of the shares of the new foreign company . In the proposed Allergan Pfizer deal , the shareholders of Allergan will own 44 percent of the merged company , while Pfizer shareholders will own 56 percent .
